Study of NM8074 in Patients With Immunoglobulin A Nephropathy (IgAN)
NCT06454110
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
10
Enrollment
INDUSTRY
Sponsor class
Conditions
IgA Nephropathy
Interventions
DRUG:
NM8074
Sponsor
NovelMed Therapeutics